DBV Technologies
Clinical-stage biopharmaceutical company developing epicutaneous immunotherapy (EPIT) treatments for food allergies, including the Viaskin platform for peanut allergy.
Location
Bagneux, France
Founded
2002
Investors
1
Categories
biotech, allergy, immunotherapy, epicutaneous, clinical-stage
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Sofinnova Partners | Paris, France | biotech-focused | seedseries-a+3 | 23 |
